Page 335 - Demo

SECTION II. APPLIED BIOTECHNOLOGY IN THE PHARMACEUTICAL INDUSTRY... 33912. Nguyen, C.T.; Dhakal, D.; Pham, V.T.T.; Nguyen, H.T.; Sohng, J.-K. Recent Advances in Strategies for Activation and Discovery/Characterization of Cryptic Biosynthetic Gene Clusters in Streptomyces. Microorganisms 2020, 8, 616.13. Xu, J.; Tozawa, Y.; Lai, C.; Hayashi, H.; Ochi, K. A rifampicin resistance mutation in the rpoB gene confers ppGppindependent antibiotic production in Streptomyces coelicolorA3(2). Mol. Genet. Genomics. 2002; 268(2):179-89.14. Nybo, S. E.; Shepherd, M. D.; Bosserman, M. A.; Rohr, J. Genetic manipulation of Streptomyces species. Curr. Protoc. Microbiol. 2010; 19, 1%u201326.15. Hesketh, A,; Ochi, K. A novel method for improving Streptomyces coelicolor A3(2) for production of actinorhodin by introduction of rpsL (encoding ribosomal protein S12) mutations conferring resistance to streptomycin. J. Antibiot.1997; 50(6):532-5.16. Tanaka, Y.; Komatsu, M.; Okamoto, S.; Tokuyama, S.; Kaji, A.; Ikeda, H.; Ochi, K. Antibiotic overproduction by rpsLand rsmG mutants of various actinomycetes. Appl. Environ. Microbiol. 2009; 75(14):4919-22.